George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients, according to a new study.
“As we learned about the connection between blood clots and COVID-19, we knew that aspirin—used to prevent stroke and heart attack—could be important for COVID-19 patients,” said Jonathan Chow, assistant professor of anesthesiology and critical care medicine and director of the Critical Care Anesthesiology Fellowship at the GW School of Medicine and Health Sciences. “Our research found an association between low dose aspirin and decreased severity of COVID-19 and death...”
